Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes | Zendy

Clemens Wittenbecher | Zendy; Meriem Ouni | Zendy; Olga Kuxhaus | Zendy; Markus Jähnert | Zendy; Pascal Gottmann | Zendy; Andrea Teichmann | Zendy; Karina Meidtner | Zendy; Jennifer Kriebel | Zendy; Harald Grallert | Zendy; Tobias Pischon | Zendy; Heiner Boeing | Zendy; Matthias B. Schulze | Zendy; Annette Schürmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes

Author(s) -

Clemens Wittenbecher,

Meriem Ouni,

Olga Kuxhaus,

Markus Jähnert,

Pascal Gottmann,

Andrea Teichmann,

Karina Meidtner,

Jennifer Kriebel,

Harald Grallert,

Tobias Pischon,

Heiner Boeing,

Matthias B. Schulze,

Annette Schürmann

Publication year - 2018

Publication title -

diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.219

H-Index - 330

eISSN - 1939-327X

pISSN - 0012-1797

DOI - 10.2337/db18-0620

Subject(s) - type 2 diabetes , diabetes mellitus , medicine , endocrinology , risk factor , insulin like growth factor binding protein , population , insulin , growth factor , insulin like growth factor , biology , environmental health , receptor

Recent studies suggest that insulin-like growth factor binding protein 2 (IGFBP-2) may protect against type 2 diabetes, but population-based human studies are scarce. We aimed to investigate the prospective association of circulating IGFBP-2 concentrations and of differential methylation in the IGFBP-2 gene with type 2 diabetes risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research